Is this you? Create Your Porfile
Avatar

Axel Riedel

Boehringer Ingelheim

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Axel Riedel is active.

Explore More

Publication

Featured researches published by Axel Riedel.

Archive | 2004

Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary, or renal diseases

Axel Riedel; Josef M. E. Leiter; Josep-Maria Sendra; Stefan Kauschke; Michael Mark

Archive | 2003

Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors

Peter Boehm; Wolf Thomas Meinicke; Axel Riedel

Archive | 2005

COMBINATION THERAPY COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE

Helmut Schumacher; Peter Böhm; Axel Riedel

Archive | 2005

Telmisartan and hydrochlorothiazide combination therapy

Helmut Schumacher; Axel Riedel; Peter Boehm

Archive | 2004

Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases

Axel Riedel; Josep-Maria Sendra; Josef M. E. Leiter; Stefan Kauschke; Michael Mark

Archive | 2004

Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases

Axel Riedel; Josep-Maria Sendra; Josef M. E. Leiter; Stefan Kauschke; Michael Mark

Archive | 2004

Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention

Lutz Hilbrich; James C. Gilbert; David Michael Humphreys; Axel Riedel

Archive | 2006

Dipyridamole, Acetylsalicylic Acid, and Angiotensin II Antagonist Pharmaceutical Compositions

James C. Gilbert; Lutz Hilbrich; Axel Riedel; David Michael Humphreys

Archive | 2005

Use of dipyridamole, acetylsalicylic acid and an angiotensin II antagonist for treatment and prevention of vascular events

James C. Gilbert; David Michael Humphreys; Lutz Hilbrich; Axel Riedel

Archive | 2003

Use of dipyridamole, acetylsalicylic acid and angiotensin ii antagonist for treatment and prevention of vascular and circulatory disorder

James C. Gilbert; Lutz Hilbrich; David Michael Humphreys; Axel Riedel

Explore More

Collaboration

Dive into the Axel Riedel's collaboration.

Top Co-Authors
Avatar

David Michael Humphreys

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

James C. Gilbert

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Josef M. E. Leiter

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Lutz Hilbrich

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Josep-Maria Sendra

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Michael Mark

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Stefan Kauschke

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Wolf Thomas Meinicke

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Peter Böhm

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Peter Boehm

Boehringer Ingelheim

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge